172 related articles for article (PubMed ID: 37968947)
1. [Predicting the presence of
Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
[TBL] [Abstract][Full Text] [Related]
2. [Severe bone complications of primary hyperparathyroidism in a young patient with the rare verified mutation of
Eremkina AK; Sazonova DV; Bibik EE; Sheikhova AZ; Khairieva AV; Buklemishev YV; Mokrysheva NG
Probl Endokrinol (Mosk); 2022 Feb; 68(1):81-93. PubMed ID: 35262299
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism].
Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
[TBL] [Abstract][Full Text] [Related]
4. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
7. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism.
Kaur G; Bhadada SK; Santra M; Pal R; Sarma P; Sachdeva N; Dhiman V; Dahiya D; Saikia UN; Chakraborty A; Sood A; Prakash M; Behera A; Rao SD
J Bone Miner Res; 2022 Oct; 37(10):1860-1875. PubMed ID: 35856247
[TBL] [Abstract][Full Text] [Related]
8. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With MEN1 and Its Genetic Profile.
Damianse SSP; Nascimento GC; Rocha VCC; Nascimento AGPAC; Gaido NC; Azulay RSS; Dos Santos WC; Rodrigues VP; Quidute ARP; Magalhães M; Dos S Faria M
Endocr Pract; 2022 May; 28(5):509-514. PubMed ID: 35247589
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
14. Genetics of parathyroid tumours.
Thakker RV
J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
[TBL] [Abstract][Full Text] [Related]
15. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
16. MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly.
Filopanti M; Verga U; Ermetici F; Olgiati L; Eller-Vainicher C; Corbetta S; Persani L; Beck-Peccoz P; Spada A
Eur J Endocrinol; 2012 Aug; 167(2):157-64. PubMed ID: 22577108
[TBL] [Abstract][Full Text] [Related]
17. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.
El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E
J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534
[TBL] [Abstract][Full Text] [Related]
18. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?
Skandarajah A; Barlier A; Morlet-Barlat N; Sebag F; Enjalbert A; Conte-Devolx B; Henry JF
World J Surg; 2010 Jun; 34(6):1294-8. PubMed ID: 20058152
[TBL] [Abstract][Full Text] [Related]
19. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
[TBL] [Abstract][Full Text] [Related]
20. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Scarpelli D; D'Aloiso L; Arturi F; Scillitani A; Presta I; Bisceglia M; Cristofaro C; Russo D; Filetti S
J Endocrinol Invest; 2004 Dec; 27(11):1015-21. PubMed ID: 15754732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
